BR9909639A - Processos para reduzir a alergenicidade de uma proteìna não humana e para produzir uma proteìna tendo reduzida alergenicidade, proteìna mutante tendo reduzida alergenicidade, dna, vetor de expressão, células hospedeiras, composição farmacêutica, e, substilisina humana - Google Patents

Processos para reduzir a alergenicidade de uma proteìna não humana e para produzir uma proteìna tendo reduzida alergenicidade, proteìna mutante tendo reduzida alergenicidade, dna, vetor de expressão, células hospedeiras, composição farmacêutica, e, substilisina humana

Info

Publication number
BR9909639A
BR9909639A BR9909639-0A BR9909639A BR9909639A BR 9909639 A BR9909639 A BR 9909639A BR 9909639 A BR9909639 A BR 9909639A BR 9909639 A BR9909639 A BR 9909639A
Authority
BR
Brazil
Prior art keywords
protein
allergenicity
human
reduced
reduced allergenicity
Prior art date
Application number
BR9909639-0A
Other languages
English (en)
Inventor
David Estell
Original Assignee
Genencor Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencor Int filed Critical Genencor Int
Publication of BR9909639A publication Critical patent/BR9909639A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

"PROCESSOS PARA REDUZIR A ALERGENICIDADE DE UMA PROTEìNA NãO HUMANA E PARA PRODUZIR UMA PROTEìNA TENDO REDUZIDA ALERGENICIDADE, PROTEìNA MUTANTE TENDO REDUZIDA ALERGENICIDADE, DNA, VETOR DE EXPRESSãO, CéLULAS HOSPEDEIRAS, COMPOSIçãO FARMACêUTICA, E, SUBTILISINA HUMANA" A presente invenção refere-se a um processo para produzir novo mutante de proteína melhorado que produz baixa resposta alergênica em humanos comparado com o ascendente deste mutante. Especificamente, a presente invenção compreende a neutralização ou redução da alergenicidade de uma proteína por introdução na mesma, como substituição ou modificação de um epítopo em tal proteína, de uma seq³ência de subtilisina humana.
BR9909639-0A 1998-04-15 1999-04-15 Processos para reduzir a alergenicidade de uma proteìna não humana e para produzir uma proteìna tendo reduzida alergenicidade, proteìna mutante tendo reduzida alergenicidade, dna, vetor de expressão, células hospedeiras, composição farmacêutica, e, substilisina humana BR9909639A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/060,854 US6642011B2 (en) 1998-04-15 1998-04-15 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
PCT/US1999/008177 WO1999053078A2 (en) 1998-04-15 1999-04-15 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins

Publications (1)

Publication Number Publication Date
BR9909639A true BR9909639A (pt) 2000-12-19

Family

ID=22032151

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909639-0A BR9909639A (pt) 1998-04-15 1999-04-15 Processos para reduzir a alergenicidade de uma proteìna não humana e para produzir uma proteìna tendo reduzida alergenicidade, proteìna mutante tendo reduzida alergenicidade, dna, vetor de expressão, células hospedeiras, composição farmacêutica, e, substilisina humana

Country Status (14)

Country Link
US (2) US6642011B2 (pt)
EP (1) EP1071792B1 (pt)
JP (1) JP2002511272A (pt)
KR (1) KR20010034785A (pt)
CN (1) CN1297483A (pt)
AT (1) ATE342365T1 (pt)
AU (1) AU3643299A (pt)
BR (1) BR9909639A (pt)
CA (1) CA2325010A1 (pt)
DE (1) DE69933551T2 (pt)
DK (1) DK1071792T3 (pt)
NO (1) NO20005152L (pt)
PL (1) PL343711A1 (pt)
WO (1) WO1999053078A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642011B2 (en) * 1998-04-15 2003-11-04 Genencor International, Inc. Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
US6838269B1 (en) * 1998-04-15 2005-01-04 Genencor International, Inc. Proteins producing an altered immunogenic response and methods of making and using the same
CA2249648A1 (en) * 1998-11-04 2000-05-04 Nabil G. Seidah Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
CN1300849A (zh) * 1999-12-21 2001-06-27 复旦大学 一种新的多肽－枯草蛋白酶10和编码这种多肽的多核苷酸
WO2001049864A1 (en) * 2000-01-06 2001-07-12 Lexicon Genetics Incorporated Novel human proteases and polynucleotides encoding the same
DE10041515A1 (de) * 2000-08-24 2002-03-14 Gerold Schuler Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen
AU2002237646A1 (en) * 2000-10-02 2002-05-27 Genencor International, Inc. Production and use of proteins producing an altered immunogenic response
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
RU2311458C2 (ru) 2001-03-23 2007-11-27 Джененкор Интернэшнл, Инк. Белки, вызывающие измененную иммуногенную реакцию, и способы их получения и использования
WO2003057713A2 (en) * 2001-12-31 2003-07-17 Genencor International, Inc. Proteases producing an altered immunogenic response and methods of making and using the same
MXPA04008144A (es) * 2002-02-26 2004-11-26 Genencor Int Proteinas de subtilisina carlsberg con inmunogenicidad reducida.
ATE532793T1 (de) * 2003-07-03 2011-11-15 Avatar Biotechnologies Inc Verfahren zur herstellung von molekülen mit verminderter immunogenität
US20090060933A1 (en) * 2004-06-14 2009-03-05 Estell David A Proteases producing an altered immunogenic response and methods of making and using the same
WO2006136160A2 (en) * 2005-06-24 2006-12-28 Novozymes A/S Proteases for pharmaceutical use
CN101243182B (zh) * 2005-08-16 2014-08-06 诺维信公司 枯草蛋白酶
AR079338A1 (es) 2009-12-09 2012-01-18 Danisco Us Inc Variantes de proteasa de bacillus y acidos nucleicos que codifican dichas variantes
WO2016112350A1 (en) * 2015-01-09 2016-07-14 Oklahoma Medical Research Foundation Methods and compositions for diagnosing and treating lysosomal storage disorders

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261868A (en) 1979-08-08 1981-04-14 Lever Brothers Company Stabilized enzymatic liquid detergent composition containing a polyalkanolamine and a boron compound
US4404128A (en) 1981-05-29 1983-09-13 The Procter & Gamble Company Enzyme detergent composition
JPS58144105A (ja) 1982-02-12 1983-08-27 Kurabo Ind Ltd スケ−ル除去獣毛繊維の製法
US4760025A (en) 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
US5155033A (en) 1989-01-06 1992-10-13 Genencor, Inc. Subtilisins modified at position 225 resulting in a shift in catalytic activity
US5763257A (en) * 1984-05-29 1998-06-09 Genencor International, Inc. Modified subtilisins having amino acid alterations
US5204015A (en) 1984-05-29 1993-04-20 Genencor International, Inc. Subtilisin mutants
US5264366A (en) 1984-05-29 1993-11-23 Genencor, Inc. Protease deficient bacillus
US5185258A (en) 1984-05-29 1993-02-09 Genencor International, Inc. Subtilisin mutants
US5182204A (en) 1984-05-29 1993-01-26 Genencor International, Inc. Non-human carbonyl hydrolase mutants, vectors encoding same and hosts transformed with said vectors
SG30639G (en) * 1986-04-30 1995-09-01 Genencor Int Non-human carbonyl hydrolase mutants DNA sequences and vectors encoding same and hosts transformed with said vectors
US4914031A (en) 1987-04-10 1990-04-03 Amgen, Inc. Subtilisin analogs
US5314692A (en) 1987-08-24 1994-05-24 Cultor Ltd. Enzyme premix for feed and method
DK6488D0 (da) 1988-01-07 1988-01-07 Novo Industri As Enzymer
CN1056187C (zh) 1988-02-11 2000-09-06 金克克国际有限公司 新的蛋白水解酶及其在洗涤剂中的应用
DE3841152A1 (de) 1988-12-07 1990-06-13 Hoechst Ag Verwendung von bakterienlysierendem enzymprodukt als zusatzstoff zur verbesserung der futterverwertung in der tierproduktion
SE8903427L (sv) 1989-10-18 1991-04-19 Vest Nova Ab Staedapparat
JP4236698B2 (ja) * 1990-11-26 2009-03-11 ジェネティックス インスティチュート，リミテッド ライアビリティ カンパニー 宿主細胞でのｐａｃｅの発現およびその使用法
DE69130113T2 (de) 1990-12-05 1999-05-12 Novo Nordisk As Proteine mit geänderten epitopen und verfahren zur deren herstellung
US5766898A (en) * 1990-12-05 1998-06-16 Novo Nordisk A/S Proteins with changed epitopes and methods for the production thereof
US5766886A (en) * 1991-12-13 1998-06-16 Xoma Corporation Modified antibody variable domains
EP0632833A1 (en) * 1992-03-09 1995-01-11 Chiron Corporation Compositions and methods for pace 4 and 4.1 gene and polypeptides in cells
DK132892D0 (da) 1992-10-30 1992-10-30 Novo Nordisk As Proteiner
US5585250A (en) * 1993-08-20 1996-12-17 The United States Of America As Represented By The Department Of Health & Human Services Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies
US5840299A (en) * 1994-01-25 1998-11-24 Athena Neurosciences, Inc. Humanized antibodies against leukocyte adhesion molecule VLA-4
GB9416841D0 (en) 1994-08-19 1994-10-12 Finnfeeds Int Ltd An enzyme feed additive and animal feed including it
JPH10510516A (ja) 1994-12-07 1998-10-13 ノボ ノルディスク アクティーゼルスカブ アレルゲン性を減らしたポリペプチド
US5837517A (en) * 1995-05-05 1998-11-17 Novo Nordisk A/S Protease variants and compositions
EP0824585B1 (en) * 1995-05-05 2009-04-22 Novozymes A/S Protease variants and compositions
CZ283972B6 (cs) * 1995-05-17 1998-07-15 František Mudr. Trnka Farmaceutický prostředek s modulačním účinkem na zhoubné nádory a jeho použití
AU5893696A (en) 1995-06-07 1996-12-30 Novo Nordisk A/S Modification of polypeptides
JP2000506119A (ja) 1996-02-15 2000-05-23 ノボ ノルディスク アクティーゼルスカブ ポリペプチドのコンジュゲーション
US6642011B2 (en) * 1998-04-15 2003-11-04 Genencor International, Inc. Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
US6835550B1 (en) * 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins

Also Published As

Publication number Publication date
AU3643299A (en) 1999-11-01
ATE342365T1 (de) 2006-11-15
DE69933551D1 (de) 2006-11-23
DE69933551T2 (de) 2007-09-06
CA2325010A1 (en) 1999-10-21
KR20010034785A (ko) 2001-04-25
JP2002511272A (ja) 2002-04-16
EP1071792A2 (en) 2001-01-31
US20020081703A1 (en) 2002-06-27
DK1071792T3 (da) 2007-02-05
NO20005152L (no) 2000-12-11
US6642011B2 (en) 2003-11-04
WO1999053078A2 (en) 1999-10-21
EP1071792B1 (en) 2006-10-11
CN1297483A (zh) 2001-05-30
NO20005152D0 (no) 2000-10-13
WO1999053078A3 (en) 2000-04-20
US20040063177A1 (en) 2004-04-01
PL343711A1 (en) 2001-08-27

Similar Documents

Publication Publication Date Title
BR9909639A (pt) Processos para reduzir a alergenicidade de uma proteìna não humana e para produzir uma proteìna tendo reduzida alergenicidade, proteìna mutante tendo reduzida alergenicidade, dna, vetor de expressão, células hospedeiras, composição farmacêutica, e, substilisina humana
EP1586649A3 (en) Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
BR0212654A (pt) Ativação e expansão de células
PT990044E (pt) Metodo para evolucao molecular in vitro da funcao de proteinas
ATE542894T1 (de) Ausweitung des eukaryotischen genetischen codes
ATE310090T1 (de) Gereinigte coprinus laccasen und nukleinsäuren welche dafür kodieren
PT1204738E (pt) Processo para a diminuicao da formacao de espuma durante a cultura de um microrganismo
AU2002254374A1 (en) Proteins producing an altered immunogenic response and methods of making and using the same
MXPA04001566A (es) Un sistema para expresion y ensamblado de anticuerpos.
BR9910332A (pt) Polipeptìdio, composição, método para purificação de polipeptìdio a partir de uma composição e método para purificação de um anticorpo a partir de uma composição
AR031912A2 (es) Subtilasa modificada, acido nucleico, vector, celula microbiana y metodo para producirla
DE69534875D1 (de) Kalziumfreie subtilisin mutanten
WO2005038002A3 (en) Site-specific incorporation of redox active amino acids into proteins
DK1530637T3 (da) Carlsberg-subtilisin-proteiner med nedsat immunogenitet
DE60102147D1 (de) Anti-gefrier proteine, deren herstellung und verwendung
DE69533626D1 (de) Tioredioxine h aus zwig und hart-weizen und ähnliche proteine, diese kodierende dna-fragmente und verfahren zu ihrer herstellung
WO2002074921A3 (en) Methods for isolating proteins expressed by dendritic cells
ATE522604T1 (de) Verfahren zur herstellung von proteinen durch elektropulsierung
BR0207757A (pt) Método para produzir uma composição de pantotenato secável por pulverização isenta de beta-alanina, e, composição de pantotenato secável por pulverização
BR9611962B1 (pt) integrante geneticamente modificado de bacillus thuringiensis ou esporo do mesmo; composiÇço pesticida; e processo para controlar uma praga.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]